BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 8242750)

  • 21. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition.
    Hoffmann I; Draetta G; Karsenti E
    EMBO J; 1994 Sep; 13(18):4302-10. PubMed ID: 7523110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity.
    Brown NR; Noble ME; Lawrie AM; Morris MC; Tunnah P; Divita G; Johnson LN; Endicott JA
    J Biol Chem; 1999 Mar; 274(13):8746-56. PubMed ID: 10085115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2.
    Song H; Hanlon N; Brown NR; Noble ME; Johnson LN; Barford D
    Mol Cell; 2001 Mar; 7(3):615-26. PubMed ID: 11463386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.
    Gu Y; Rosenblatt J; Morgan DO
    EMBO J; 1992 Nov; 11(11):3995-4005. PubMed ID: 1396589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation and activation of the Xenopus Cdc25 phosphatase in the absence of Cdc2 and Cdk2 kinase activity.
    Izumi T; Maller JL
    Mol Biol Cell; 1995 Feb; 6(2):215-26. PubMed ID: 7787247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutant.
    Yeh CT; Lu SC; Chao CH; Chao ML
    Biochem Biophys Res Commun; 2003 May; 305(2):311-4. PubMed ID: 12745075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential activation of cyclin and cyclin-dependent kinase genes by adenovirus E1A12S cDNA product.
    Ishii T; Shimizu M; Kanayama Y; Nakada S; Nojima H; Oda K
    Exp Cell Res; 1993 Oct; 208(2):407-14. PubMed ID: 8375470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines.
    Yang R; Morosetti R; Koeffler HP
    Cancer Res; 1997 Mar; 57(5):913-20. PubMed ID: 9041194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
    Lees E; Faha B; Dulic V; Reed SI; Harlow E
    Genes Dev; 1992 Oct; 6(10):1874-85. PubMed ID: 1398067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E2F1, B-myb and selective members of cyclin/cdk subunits are targets for protein kinase C-mediated bimodal growth regulation in vascular endothelial cells.
    Zhou W; Takuwa N; Kumada M; Takuwa Y
    Biochem Biophys Res Commun; 1994 Feb; 199(1):191-8. PubMed ID: 8123011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of HTm4 to cyclin-dependent kinase (Cdk)-associated phosphatase (KAP).Cdk2.cyclin A complex enhances the phosphatase activity of KAP, dissociates cyclin A, and facilitates KAP dephosphorylation of Cdk2.
    Chinami M; Yano Y; Yang X; Salahuddin S; Moriyama K; Shiroishi M; Turner H; Shirakawa T; Adra CN
    J Biol Chem; 2005 Apr; 280(17):17235-42. PubMed ID: 15671017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of cyclin-dependent kinase 2 activity by ceramide.
    Lee JY; Bielawska AE; Obeid LM
    Exp Cell Res; 2000 Dec; 261(2):303-11. PubMed ID: 11112337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
    Braun K; Hölzl G; Soucek T; Geisen C; Möröy T; Hengstschläger M
    Oncogene; 1998 Oct; 17(17):2259-69. PubMed ID: 9811456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of cdk2 kinase with the transcription factor E2F during S phase.
    Pagano M; Draetta G; Jansen-Dürr P
    Science; 1992 Feb; 255(5048):1144-7. PubMed ID: 1312258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages.
    Matsuoka M; Tani K; Asano S
    Oncogene; 1998 Apr; 16(16):2075-86. PubMed ID: 9572488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative splicing of human cyclin E.
    Sewing A; Rönicke V; Bürger C; Funk M; Müller R
    J Cell Sci; 1994 Feb; 107 ( Pt 2)():581-8. PubMed ID: 8207080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma.
    Yeh CT; Lu SC; Chen TC; Peng CY; Liaw YF
    Cancer Res; 2000 Sep; 60(17):4697-700. PubMed ID: 10987270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The differential catalytic activity of alternatively spliced cdk2 alpha and cdk2 beta in the G1/S transition and early S phase.
    Kwon TK; Buchholz MA; Jun DY; Kim YH; Nordin AA
    Exp Cell Res; 1998 Jan; 238(1):128-35. PubMed ID: 9457065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.